Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma. Ishio T, Kumar S, Shimono J, Daenthanasanmak A, et al. Blood 2021 Nov 24. pii: 482776. doi: 10.1182/blood.2021012734.

Read + Share

Amedeo Smart

Independent Medical Education

Ishio T, Kumar S, Shimono J, Daenthanasanmak A, et al. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma. Blood 2021 Nov 24. pii: 482776. doi: 10.1182/blood.2021012734.
PMID: 34818414